© 2026 Zoe. All rights reserved.
Zoe is a legal information platform. Always consult the Federal Register of Legislation for authoritative text.
[2022] WASCA 109
Court of Appeal (WA)
2022-08-24
Buss P
Original judgment source is linked above.
(a) prescribing certain drugs or substances to patients in circumstances where there was no therapeutic indication or clinical justification basis for doing so, thereby unnecessarily exposing his patients to the risk of adverse effects of those drugs or substances;
(b) ordering blood tests without any proper or adequate consideration as to the necessity of those blood tests, thereby exposing the patients to potential unnecessary testing;
(c) failing to record in his notes the substances he prescribed to particular relevant patients; and
(d) failing to take an appropriate medical history and conduct an appropriate examination when consulting with particular patients.
(a) subject to condition B, the practitioner must not prescribe, supply, administer, handle, dispense or access (access), including as emergency treatment supplies or doctor's bag stock, the following substances:
(ii) testosterone in any form, including Primoteston Depot or Reandron;
(iii) any steroid with an anabolic and/or androgenic effect, including Danazol;
(iv) any aromatase inhibitor, including anastrozole;
(v) dehydroepiandrosterone (DHEA);
(vi) any stimulants, including phentermine and salbutamol;
(vii) thyroid extract.
(b) Condition (a) does not apply to the respondent's access to salbutamol for administration by inhalation or intravenous infusion for the management of:
(i) acute bronchospasm before or after an interventional radiology procedure; or
(ii) acute asthmatic attack before or after an interventional radiology procedure.
(c) Before resuming practice as an interventional radiologist the respondent must satisfy the applicant that he has the clinical skills that will allow him to do so safely.
(d) Within 21 days notice of the imposition of these conditions, the practitioner must provide to AHPRA:
(i) acknowledgement, on the approved form (HP1), that AHPRA may obtain reports from a senior person, such as the Director of Medical Services, Director of Nursing, Senior Practice Manager, Senior Partner, Proprietor, Owner or equivalent (the senior person) at each and every place of practice on a monthly basis or as otherwise required by the Board or AHPRA;
(ii) acknowledgement, on the approved form (HP1) that, for the purposes of monitoring compliance with the condition restricting access to the medication, AHPRA may contact Medicare and/or drugs and poisons regulatory authorities in relevant states or territories; and
(iii) confirmation, on the approved form (HPS1), from the senior person at each place of practice that they are aware AHPRA will seek reports from them.
(e) Within 21 days' notice of the imposition of these conditions, the practitioner must provide to AHPRA, on the approved form (HPC), the contact details of a senior person, such as the Director of Medical Services, Director of Nursing, Senior Practice Manager, Senior Partner, Proprietor, Owner or equivalent (the senior person), at each current place of practice. In providing this form, the practitioner acknowledges that AHPRA will contact the senior person and provide them with a copy of the conditions on the practitioner's registration or confirm that the senior person has received a copy of the conditions from the practitioner. The practitioner will be required to provide the same form:
(i) within 7 days of the commencement of practice at each subsequent place of practice; and
(ii) within 7 days of each and every notice of any subsequent alteration of these conditions.
(f) All costs associated with compliance with the conditions on his registration are at the respondent's own expense.
(g) The review period of six months is set for the conditions imposed on the respondent's registration, with the review period to start on 16 June 2023.
(1) Until the determination by this court of Dr Nadkarni's appeal (including Dr Nadkarni's application for leave to appeal) or further order of this court, the operation of orders 2, 3(c) and 3(g) of the [Tribunal's] orders dated 21 September 2021 is stayed.
(2) Until the determination by this court of Dr Nadkarni's appeal (including Dr Nadkarni's application for leave to appeal), order 3 (apart from order 3(c) and 3(g)) of the [Tribunal's] orders dated 21 September 2021 operates with effect from 13 October 2021.
The relevant provisions of the HPR Act and the Health Practitioner National Law
(a) the practitioner has no case to answer and no further action is to be taken in relation to the matter (s 196(1)(a)); or
(b) one or more of a number of specified conclusions, including that the practitioner has behaved in a way that constitutes unprofessional conduct or professional misconduct (s 196(1)(b)).
(a) caution or reprimand the practitioner;
(b) impose a condition on the practitioner's registration, including, for example -
(i) a condition requiring the practitioner to complete specified further education or training, or to undergo counselling, within a specified period; or
(ii) a condition requiring the practitioner to undertake a specified period of supervised practice; or
(iii) a condition requiring the practitioner to do, or refrain from doing, something in connection with the practitioner's practice; or
(iv) a condition requiring the practitioner to manage the practitioner's practice in a specified way; or
(v) a condition requiring the practitioner to report to a specified person at specified times about the practitioner's practice; or
(vi) a condition requiring the practitioner not to employ, engage or recommend a specified person, or class of persons;
(c) require the practitioner to pay a fine of not more than $30 000 to the National Board that registers the practitioner;
(d) suspend the practitioner's registration for a specified period;
(e) cancel the practitioner's registration.
(1) Unless otherwise specified in this Act, the enabling Act, or an order of the Tribunal under this section, parties bear their own costs in a proceeding of the Tribunal.
(2) Unless otherwise specified in the enabling Act, the Tribunal may make an order for the payment by a party of all or any of the costs of another party or of a person required to produce a document or other material on the application of the party under section 35.
(3) The power of the Tribunal to make an order for the payment by a party of the costs of another party includes the power to make an order for the payment of an amount to compensate the other party for any expenses, loss, inconvenience, or embarrassment resulting from the proceeding or the matter because of which the proceeding was brought.
(1) A party to a proceeding may appeal from a decision of the Tribunal in the proceeding, but only if the court to which the appeal lies gives leave to appeal.
(2) The appeal can only be brought on a question of law.
...
(9) The court dealing with the appeal may -
(a) affirm, vary, or set aside the decision of the Tribunal; or
(b) make any decision that the Tribunal could have made in the proceeding; or
(c) send the matter back to the Tribunal for reconsideration, either with or without the hearing of further evidence, in accordance with any directions or recommendations that the court considers appropriate,
and, in any case, may make any order the court considers appropriate.
(10) If the court sends the matter back to the Tribunal under subsection (9)(c), it is to give directions as to whether or not the Tribunal reconsidering the matter is to be constituted by the member or members who made the original decision.
...
(13) Despite subsection (2), if the Tribunal's decision -
(a) is made under a relevant Act or in a proceeding for the review of a decision made under a relevant Act; and
(b) has the effect of depriving a person of the person's capacity to lawfully pursue a vocation,
an appeal under this section may be brought on any ground whether it involves a question of law, a question of fact or a question of mixed law and fact.
(a) an Act specified in Schedule 1, if it is an enabling Act; or
(b) an enabling Act prescribed by the regulations for the purposes of subsection (13).
The Tribunal's reasons including its findings of fact
(a) Dr Nadkarni was not acting as a radiologist when he engaged in the professional misconduct. Rather, Dr Nadkarni did so in the course of practising 'integrative medicine'. This area of practice is also referred to as 'wellness' or 'anti‑ageing'. Dr Nadkarni accepted that his professional misconduct put his patients' health at risk [3].
(b) Dr Nadkarni had ceased to prescribe the particular substances concerned and was winding up his integrative medicine practice. Dr Nadkarni had also undertaken courses to ensure that he is better informed as to the manner in which proper notes should be taken, better placed to ensure that he is aware of the manner in which a clinical history should be taken and better trained to ensure compliance with prescribing practices [4].
(c) There was no suggestion that Dr Nadkarni's skills and experience in radiology were less than satisfactory. Indeed, his references illustrated Dr Nadkarni's competence as a radiologist and the contribution he makes to that area of medicine [5].
(a) from about 2010, Dr Nadkarni commenced prescribing human growth hormone, anabolic androgenic steroids (in various forms), testosterone (in various forms), stimulants (in various forms), anastrozole, dehydroepiandrosterone and thyroid extract to patients in the absence of any proper therapeutic indication or clinical justification for the prescribing of those drugs and substances and unnecessarily exposed his patients to the risk of adverse effects of those drugs or substances;
(b) from December 2012 to July 2017, Dr Nadkarni did not record, within his clinical notes relating to nine patients, all of the substances that Dr Nadkarni had prescribed to those patients;
(c) from June 2014 to January 2017, Dr Nadkarni ordered, in relation to four patients, blood tests without proper or adequate consideration as to the necessity for those blood tests, thereby exposing those patients to potentially unnecessary testing; and
(d) from June 2014 to January 2017, Dr Nadkarni failed to take an appropriate medical history and conduct appropriate examinations when consulting with four patients.
Dr Nadkarni's primary area of expertise is in interventional radiology and endovascular radiology.
Dr Nadkarni is not a specialist endocrinologist. He holds no formal qualifications in relation to endocrinology.
In 2005 Dr Nadkarni established Endovascular WA. It was his private interventional radiology practice. Through that business Dr Nadkarni carried out:
Before establishing Endovascular WA, Dr Nadkarni had been working four days per week at Sir Charles Gairdner Hospital (SCGH) and one day per week at Stirling Radiology. Upon the establishment of Endovascular WA, Dr Nadkarni worked two days per week at that business and three days per week at SCGH. Although Endovascular WA is principally an interventional radiology practice, from between 2005 until 2012 Dr Nadkarni administered botox injections through Endovascular WA.
In 2009 Dr Nadkarni also established another business called New Life Clinic WA. At all relevant times New Life Clinic carried on the business of providing various 'anti-aging' treatments and cosmetic medical services. It was in relation to his work at New Life Clinic that Dr Nadkarni's professional misconduct occurred.
In 2020 Dr Nadkarni commenced another business called Precision Radiology WA. He says, and we accept, that the purpose of the business is to support the procedures which he performs at Endovascular WA and to offer diagnostic radiology services to referring doctors. (footnotes omitted)
Dr Nadkarni's unchallenged evidence which we accept is that he currently works:
Dr Nadkarni is also on the WA Health Register to assist in a general medicine capacity in case of an outbreak of COVID-19 in Perth or the surrounding regions.
Dr Nadkarni is an Adjunct Clinical Associate Professor at the Curtin School of Medicine. He is not paid in that position, which involves administering examinations to students and in providing placements at Endovascular WA and Precision Radiology to final year medical students. This commitment involves two days per year examining students and 12 - 18 weeks mentoring and teaching.
In addition, Dr Nadkarni provides educational sessions to general practitioners on developments in interventional radiology and has presented seminars at the annual meetings of the Australian College of Phlebology and the Annual Interventional Radiology Society of Australia.
Dr Nadkarni is in the process of winding down the business of New Life Clinic. He says this is because he wishes to focus his interests on diagnostic and interventional radiology and because he no longer wishes to have a dermal therapy business in his 'business portfolio'. Dr Nadkarni's evidence is that New Life Clinic's website, Facebook page and Instagram profile were all deactivated during the week beginning 5 July 2021.
Dr Nadkarni has had to take a leave of absence from SCGH since the findings of professional misconduct were made. He has been informed by the Director of Medical Services that it is likely that he will lose his position at SCGH if his registration is suspended or cancelled.
At all times during his practice at both Endovascular WA and New Life Cosmetics, Dr Nadkarni held himself out to be an interventional radiologist with qualifications in anaesthetics, medicine, radiology and phlebology.
From those facts we find that Dr Nadkarni is a very experienced and highly qualified specialist doctor. He was well aware that prescribing the substances he did, was really the province of endocrinologists and also that the way he was using them to treat symptoms of fatigue, lassitude, poor libido, poor sleep, generalised joint and soft tissue pain and weight gain, was not what the substances were approved for and that they would not have been prescribed by an endocrinologist to a patient presenting with those symptoms. (footnotes omitted)
Dr Nadkarni's evidence is that he had always had an interest in general medicine and became interested in integrative medicine in about 2005 when patients attending Endovascular WA expressed to him a level of dissatisfaction about the medical treatment they were receiving from their general practitioners for symptoms such as fatigue, lassitude, poor libido, poor sleep, generalised joint and soft tissue pain and weight gain.
Dr Nadkarni's evidence is that he began to investigate available intervention and management options for these presentations in the hope of being able to add an integrative and holistic element to his practice. At about that same time he was attending local workshops on the use of botox and fillers and it was at those events that he met general practitioners who were also practising integrative medicine. His evidence was that synthetic and bio-identical hormones are the mainstay of treatment in integrative medicine and were the subject of workshops and meetings he attended. He was made aware of the existence of the Australian College of Anti-Aging Medicine (A4M) and the American College of Anti-Aging Medicine (A5M) which were offering courses and online education with a focus on symptom management and the use of synthetic and bio-identical hormones to balance and optimise hormone levels. He also became aware of the Australian College of Nutritional and Environmental Medicine.
Dr Nadkarni says, and we accept, that over the next 10 years he attended many courses and conferences for managing the symptoms for which he was prescribing the medications and found all of the information provided 'very convincing' and led him to believe that prescribing the medications in the way he did was clinically justified. In his Supplementary Statement of Evidence, Dr Nadkarni stated:
(a) the number of medical practitioners who attended the conferences I attended;
(b) the content of presentations (which included the mechanism of action of the various hormones on body composition, mood, libido, well-being, lethargy and fatigue) and their purported support by what was promoted as current evidence-based literature;
(c) my interpretation of the literature I had read;
I formed the impression that there was genuine science behind the use of synthetic and bio-identical hormones, stimulants and aromatase inhibitors to manage symptoms that the patients the subject of these proceedings presented with. It was this impression that caused me to form a usual practice when providing integrative medicine services to patients which, on reflection, I now regret.
In cross-examination Dr Nadkarni gave evidence to the effect that he understood that endocrinologists, specialists who treat people with hormone irregularities, would not prescribe the substances he had done to patients presenting with the symptoms he was endeavouring to treat. The following exchange between counsel for the Board and Dr Nadkarni took place:
... and I felt - based on having attended these meetings and having some knowledge of these through my studies, I thought at that time it was clinically justified to be offering different treatments and following them up.
So you thought that the patients would be better off having that treatment from you than being referred to an endocrinologist? - - - Not necessarily. They would be referred to endocrinologists but the endocrinologists weren't prepared to offer them any form of treatment for their symptoms.
Well if you have embarked on treating them with hormone therapy, does that not indicate that you decided that they're better off being treated by you than an endocrinologist? - - - Look, I - I mean, it's - it's debatable. I don't think that they're better off being treated by me, but they are getting some form of a treatment that's helping with their symptoms. They come back, they tell you they're feeling better ...
We accept Dr Nadkarni's evidence that his prescribing practice was the result of a genuine desire to offer holistic services to patients and a mistaken understanding that there was a clinical justification for prescribing the substances he did. (footnotes omitted)
The radiologists who have written references for Dr Nadkarni speak of the contribution that Dr Nadkarni makes to this field of medicine, either as a speaker at scientific meetings, [or] through his skills in phlebology and interventional radiology.
Dr Joseph Hockley, Acting Head of Department Vascular and Endovascular Surgery at Sir Charles Gardner Hospital wrote that Dr Nadkarni remains a valuable member of the Vascular team at the hospital. He states:
Were he unable to practice here his loss would be very difficult to cover and would undoubtedly impact on the department's ability to provide its current service.
Country practitioners have written of the benefit that Dr Nadkarni makes to the lives of rural patients because, through Endovascular WA he provides a service to rural patients who have no other local service provider. It is said that not only does he provide a service in the country but that he is flexible in his billing practices and where patients do not have the capacity to be treated as private patients Dr Nadkarni treats them as public patients. The alternative would be having to travel to Perth to be treated as a private patient or having to wait for very long periods of time to be treated in Perth as a public patient. This means that they are seen much more quickly than would be the case if they were to have to wait to be treated as public patients in Perth. Dr Sakarapani says:
Many of my patients have commented to me on the quality of care provided to them by Dr Nadkarni. He is an excellent interventional radiologist with a wide skill set and he provides a very needed service to my rural patients.
Dr Hartley wrote:
If Dr Nadkarni was not able to continue to provide interventional Radiology services in the South West in particular, but also in Perth, a hugely beneficial pathway of management with [sic] be lost to not only myself, but all of the referring GPs in the South West region.
Doctors who refer patients to Dr Nadkarni have written of his vast experience in the diagnosis and management of musculoskeletal and chronic pain, varicose vein ablation and management of pelvic pain. (footnotes omitted)
(a) Dr Nadkarni had ceased to practise integrative medicine [57].
(b) Dr Nadkarni no longer prescribes the substances the subject of the disciplinary proceedings [57].
(c) Dr Nadkarni no longer orders blood tests for patients without first examining and assessing the patient personally [57].
(d) Dr Nadkarni is genuinely remorseful for his professional misconduct [58].
(e) Although Dr Nadkarni's agreement to the characterisation of his conduct as professional misconduct came 'late in the piece', Dr Nadkarni's insight into the risks to which he exposed his patients by his prescribing practices and Dr Nadkarni's remorse are genuine [60].
(f) Dr Nadkarni had completed training in relation to the keeping of adequate notes and records [62].
(g) As a result of an online course he had completed, Dr Nadkarni realised that his historical note keeping had been substandard on occasions in particular respects and that he had failed to record clearly in his notes the medications he had prescribed for his patients [62].
(a) the penalty included a reprimand in all cases;
(b) where cancellation of the practitioner's registration had not been imposed, suspension had been imposed in almost all cases;
(c) in most cases, a condition restricting the practitioner from prescribing the substances involved in their misconduct had been imposed; and
(d) in many cases, the practitioner had been required to permit the auditing of their practice at their own expense [73].
The fact that a doctor of Dr Narkarni's [sic] experience, would prescribe such substances, without therapeutic justification, to many (albeit an unknown number of) patients over a lengthy period of time, thereby exposing those patients to risks of serious adverse consequences is a serious example of professional misconduct. That misconduct was compounded by the other failings which Dr Nadkarni has admitted in these proceedings.
First, as we have said, we have come to the view that Dr Nadkarni's professional misconduct is to be characterised as a serious example of its kind.
Second, we have come to the view that protecting the public by deterring Dr Nadkarni from behaving in this manner in the future is not the most significant feature of the penalty to be imposed in this case because:
Third, we have formed the view that the protection of the public from the possibility of a repeat of Dr Nadkarni's misconduct (if we do not cancel his registration and impose a period of disqualification) could be addressed by imposing conditions upon his registration which restrain him from prescribing the particular substances the subject of these proceedings or substances of the like type.
Fourthly, we have come to the view that, in addition to the issuing of a reprimand, a period of suspension or disqualification is required in order to mark the seriousness of Dr Nadkarni's professional misconduct. Nothing less would, in our view, suffice in circumstances where a doctor of such extensive training and experience, who should be expected to have known better as a result of that training and experience, has put patient safety at risk over an extensive period of time by his misconduct.
Fifthly, the protection of the public by the imposition of a sanction which should act as a deterrence to others who may consider embarking on the same kind of behaviour is only likely to be achieved by the imposition of a term of suspension or cancellation of his registration. If a specialist with as much training and experience as Dr Nadkarni, who must understand the importance of evidence based medicine, can come to regard the prescribing of these substances to patients presenting with the problems Dr Nadkarni thought he was alleviating, even knowing that specialist endocrinologists would not do so, then other practitioners may be at risk of similar misconduct. There is, therefore, a heightened need for general deterrence in the penalty to be imposed on Dr Nadkarni.
Sixthly, we consider that in the circumstances, the need to protect the public and maintain public confidence in the profession by reinforcing high professional standards and denouncing transgressions is an important factor in imposing a penalty. The public is entitled to expect that their doctors will treat their symptoms based upon evidence-based medicine. The fact that someone as experienced as Dr Nadkarni could regard his prescribing practice as justified, speaks to the need to deter others from following in his footsteps and to ensure the public, who repose a great deal of trust in practitioners by reason of their supposed skill, training and expertise, can be confident in their treatment.
Seventhly, while Dr Nadkarni's conduct fell below the high standards which are to be expected of someone of his profession, we do not find that he lacks the character and trustworthiness necessary to discharge the responsibilities of his profession such that he should be assumed to be permanently or indefinitely unfit to be registered.
Eighthly, while we have regard to the fact that Dr Nadkarni is the sole breadwinner for his young family and that any period of disqualification or suspension will almost inevitably have an impact upon that family, we have already referred to the general principle that personal hardship which may be suffered by the practitioner and his or her family is a secondary consideration in matters of this kind. There is nothing in the material which was provided to us that would suggest any hardship would be exceptional in nature.
Ninthly, Dr Nadkarni's evidence is that if he were to be suspended from practice for a period of more than six months, the staff he employs will be likely to lose their jobs. We give that issue no weight in determining penalty. As regrettable as that consequence may be, having regard to the purposes of imposing penalties under the National Law we cannot be influenced by that consideration. The appropriate penalty in this case cannot be moderated to ensure that Dr Nadkarni's employees' employment is maintained.
Tenthly, while it is also inevitable that the loss, temporary or otherwise, of Dr Nadkarni's provision of radiological services which will flow from a period of suspension will inconvenience SCGH and likely cause delays in some country patients receiving affordable medical treatment, there is nothing in the materials before us that would allow us to form the conclusion that Dr Nadkarni is possessed of special and exceptional skills which are so limited within the medical community in Western Australia that notwithstanding that the behaviour would otherwise warrant a period of suspension or disqualification, a different course should be taken in his case to ensure that his skills and expertise is not lost to the public.
Finally, Dr Nadkarni has expressed some concern that if he is unable to practice in his area of specialty for any significant period of time the result may be that he loses the skills essential to the practice of interventional radiology which requires precision in the injecting of veins which is both attained and maintained by regularly doing so. We acknowledge that risk exists. It may be that some refresher training or a period of supervision will be required following Dr Nadkarni's return to practice to ensure that he remains sufficiently skilled. In our view, the risk can be adequately addressed by other means.
Having had regard to all of these matters, in particular that there was no dishonesty or incompetence of a kind that would render him permanently unfit to practise in his profession, we have come to the conclusion that a reprimand and the suspension of Dr Nadkarni's registration for a period of 20 months, together with conditions which will have effect upon his return to practice, will adequately reflect the seriousness of the professional misconduct and ensure the protection of the public and that the cancellation of his registration is not required.
Given that we have accepted Dr Nadkarni's assurances that he no longer intends to practice other than as a specialist radiologist, we do not consider that it is necessary to impose a condition which would restrict him to practising as a radiologist upon his return to practice. We do however, consider that preventing him from prescribing the substances involved in this matter in any form, subject to the one exception sought in respect of salbutamol, is appropriate.
In order to address the possibility that Dr Nadkarni will become deskilled during his suspension, we will impose a condition on his registration requiring him to satisfy the applicant that he has the skills to enable him to undertake interventional radiology before recommencing practice.
We consider that a review period for the conditions of 6 months is appropriate.
The parties have agreed that Dr Nadkarni will pay a contribution to the Board's costs. We consider that is an appropriate order to make in this case. (footnotes omitted)
(a) the facts and circumstances of Dr Nadkarni's conduct relevant to penalty;
(b) the outcome in comparable cases of professional misconduct under the National Law; and
(c) the objects and principles embodied in the National Law,
the suspension of Dr Nadkarni's registration as a medical practitioner for a period of 20 months was manifestly excessive.
(a) Dr Nadkarni's registration as a medical practitioner is suspended for a period of 20 months; and
(b) from the date of expiry of that period of suspension, his registration becomes subject to a condition that, before resuming practice as an interventional radiologist, Dr Nadkarni must satisfy the Board that he has the clinical skills to do so safely.
(a) By s 196(2), a suspension must be for a fixed period.
(b) The practical effect of order 2 and order 3(c) in combination is that Dr Nadkarni's specialist registration in radiology has not been suspended for a fixed period.
(c) Order 3(c) does not stipulate any adequately defined mechanism by which Dr Nadkarni can seek to satisfy the Board as to his competence and gives the Board an unfettered discretion to determine those matters.
(d) The form of order 3(c) is not conducive to any means of expeditious dispute resolution under the National Law consistent with the guiding principle that the National Law is to operate in a transparent, accountable, effective and fair way. See s 3(3)(a) of the National Law.
(e) There are obvious practical difficulties that are likely to arise in Dr Nadkarni satisfying the condition imposed by order 3(c). In particular, after the expiry of the period of suspension, Dr Nadkarni could not demonstrate his clinical skills in interventional radiology by doing anything as part of the practice of interventional radiology.
The fact that someone as experienced as Dr Nadkarni could regard his prescribing practice as justified, speaks to the need to deter others from following in his footsteps and to ensure the public, who repose a great deal of trust in practitioners by reason of their supposed skill, training and expertise, can be confident in their treatment [88].
A contrast is often drawn between orders made for the protection of the public, against professionals who have departed from proper professional standards, and orders or sentences by way of punishment as part of the administration of the criminal law.
While there is a fundamental difference between an order made by a professional disciplinary tribunal for the protection of the public, and a punishment imposed by a court administering the criminal law, disciplinary orders made by professional bodies may nevertheless have elements in common with criminal sanctions.
In the case of a professional disciplinary tribunal, an obvious type of order protective of the public is an order cancelling the registration or recognition of a person as a member of a profession. Such an order removes the right to practise in the profession, thereby protecting the public against a person found unfit to be a practitioner. And, as Evatt [The New South Wales Bar Association v Evatt [1968] HCA 20; (1968) 117 CLR 177] shows, such an order will be made even though, if punishment of the practitioner were the only consideration, considerations of mercy might lead to a less severe order.
In other cases the protection of the public or the public interest may justify an order intended to bring home to the practitioner the seriousness of the practitioner's departure from professional standards, and intended to deter the practitioner from any further departure. A fine might well be imposed with this object. An order imposing a fine might look like a punishment imposed by a court exercising criminal jurisdiction, but in professional disciplinary proceedings it is imposed on a different basis. An order might also be made in professional disciplinary proceedings to emphasise to other members of the profession, or to reassure the public, that a certain type of conduct is not acceptable professional conduct. In the latter case the order is made in part to protect the profession, by demonstrating that the profession does not allow certain conduct. This, in the end, is also in the public interest.
I make these points merely to emphasise that the protection of the public has various aspects. The public may be protected by preventing a person from practising a profession, by limiting the right of practice, or by making it clear that certain conduct is not acceptable. These are merely illustrations of the sort of order that may be called for [44] ‑ [48].
(a) Dr Nadkarni's prescribing practices, in the context of his practice of integrative medicine, were the result of a genuine desire to offer holistic services to patients and a mistaken understanding that there was a clinical justification for prescribing the substances he did.
(b) Dr Nadkarni had ceased to practice integrative medicine.
(c) Dr Nadkarni no longer prescribed the substances in question.
(d) Dr Nadkarni no longer ordered blood tests for patients without first examining and assessing the patient personally.
(e) Dr Nadkarni was genuinely remorseful for his professional misconduct.
(f) Dr Nadkarni was unlikely to repeat the professional misconduct.
(g) Dr Nadkarni had eventually gained insight into the risks to which he had exposed his patients by his prescribing practices.
(h) Dr Nadkarni had completed training in relation to maintaining adequate notes and records.
(i) Dr Nadkarni had no previous disciplinary history.
(j) There was no suggestion that Dr Nadkarni's skills and experience in radiology were less than satisfactory. References from professional colleagues illustrated Dr Nadkarni's competence as a radiologist and the contribution he has made and continues to make to that area of medicine. Dr Nadkarni has vast experience in the diagnosis and management of musculoskeletal and chronic pain, varicose vein ablation and management of pelvic pain. He appears to be an excellent interventional radiologist with a wide skill set.
(k) Having ceased to practice integrative medicine, Dr Nadkarni will focus on providing diagnostic radiological services and interventional radiological services.
(l) Dr Nadkarni did not lack the character and trustworthiness necessary to discharge the responsibilities of his profession. Dr Nadkarni's professional misconduct did not involve dishonesty or incompetence of a kind that would render him permanently unfit to practise his profession.
(a) personal hardship for Dr Nadkarni and his young family in that Dr Nadkarni is the family's sole income earner;
(b) if Dr Nadkarni were to be suspended from practice for more than six months, his staff would be likely to become unemployed; and
(c) the loss of Dr Nadkarni's provision of radiological services would inconvenience Sir Charles Gairdner Hospital and cause delays in some country patients receiving affordable medical treatment.
(a) 'a condition requiring [Dr Nadkarni] to complete specified further education or training ... within a specified period' (s 196(2)(b)(i));
(b) 'a condition requiring [Dr Nadkarni] to undertake a specified period of supervised practice' (s 196(2)(b)(ii)).
Before resuming practice as an interventional radiologist [Dr Nadkarni] must satisfy [the Board] that he has the clinical skills that will allow him to do so safely.
A review period of six months is set for the conditions imposed on [Dr Nadkarni's] registration, with the review period to start on 16 June 2023.
It may be that some refresher training or a period of supervision will be required following Dr Nadkarni's return to practice to ensure that he remains sufficiently skilled. In our view, the risk can be adequately addressed by other means [93].
(a) the Tribunal itself had formulated order 3(c);
(b) it was not part of the Board's case before the Tribunal that order 3(c) was necessary; and
(c) there was no evidence before the Tribunal as to how Dr Nadkarni could satisfy the Board or what the Board could require of Dr Nadkarni in connection with the condition embodied in order 3(c) (appeal ts 59).
(a) the word 'specified' in s 196(2)(b)(i) means that the condition requiring the practitioner to complete 'specified further education or training' must state with reasonable precision or in reasonable detail the further education or training that the practitioner must complete; and
(b) the word 'specified' in s 196(2)(b)(ii) means that the condition requiring the practitioner to undertake a 'specified period of supervised practice' must state specifically or explicitly the length of the period and the date on which the period is to commence.
The orders that this court should make in the appeal
(a) this court's exercise of the discretionary power will be based upon primary facts already found by the Tribunal or upon undisputed evidence (so that a further hearing to find facts is unnecessary);
(b) this court is in as good a position as the Tribunal (including having regard to the Tribunal's status as a specialist tribunal) in relation to the exercise of the discretionary power; and
(c) this court's exercise of the discretionary power would achieve a convenient disposition of the matter and avoid the expense and inconvenience of remitting the matter to the Tribunal.
(a) the purpose of disciplinary proceedings against medical practitioners (in particular, the protection of the public and the maintenance of high professional standards);
(b) the findings of fact made by the Tribunal in its reasons;
(c) the numerous sanction or penalty options available under s 196(2);
(d) the sanctions or penalties that have been imposed in previous cases which are, at least to some extent, reasonably comparable;
(e) the importance of personal and general deterrence;
(f) Dr Nadkarni's personal circumstances and antecedents; and
(g) the mitigating factors,
that Dr Nadkarni's registration as a medical practitioner should be suspended for a period of eight months.
Schmuelly v Professional Standards Committee Inquiry (2010)
Health Care Complaints Commission v Zacharia[21]
[E]mbarked on an area of practice for which he was ill-equipped through training and education and, most significantly, in the absence of scientific and medical research to a standard that allowed that practice to be undertaken with confidence that it presented no risk of harm to his patients [247].
(a) not to possess, administer, prescribe or supply a number of drugs, including HGH and most anabolic or androgenic steroids;
(b) not to advertise health services regarding 'anti‑ageing' medicine as it involves the use of any of the drugs he is prohibited from possessing, administering, prescribing or supplying; and
(c) to complete the distance medical ethics course offered by Monash University.
Medical Board of Australia v Grant[22]
(a) undertake a tertiary level course in prescribing practices;
(b) undertake a course approved by the Board to develop skills for managing difficult interactions with patients;
(c) not deal with the relevant drugs in any way, or seek the return of his endorsement to do so;
(d) allow and pay for the Board to audit his patient records;
(e) nominate a mentor with whom he must meet monthly to reinforce sound prescribing practices and skills in managing interactions with patients; and
(f) provide a copy of these orders and reasons to his employer and mentor.
Health Care Complaints Commission v Epstein[23]
(a) Dr Epstein first obtained written approval to prescribe as proposed from an Australian endocrinologist of her choice who has reviewed the patient's records and the proposed treatment plan; or
(b) the patient was reviewed by the endocrinologist and Dr Epstein's treatment plan was approved by the endocrinologist.
Medical Board of Australia and Singh[25]
Medical Board of Australia v Hadges[30]
(a) restricting his areas of practice to general practice and/or practice as a surgical assistant;
(b) prohibiting him from performing cosmetic medicine or surgical procedures;
(c) requiring him to be under supervision by another medical practitioner when practising;
(d) requiring him to only practise at Board-approved places of practice;
(e) prohibiting him from prescribing, supplying or administering anabolic steroids and other particular classes of drugs; and
(f) completing education on various topics, including clinical management, investigations, review of treatment, prescribing, informed consent and coordination of care.
Medical Board of Australia v Tunbridge[31]
Medical Board of Australia v Marzola[32]
(a) prohibiting him from in any way accessing and prescribing any of the medication the subject of the proceedings;
(b) that his practice be subject to quarterly audits by a Board approved auditor; and
(c) that his medical practice be restricted to specified areas of clinical activity,
with these conditions subject to a 12-month review by the Board. Dr Marzola was further required to pay a fine of $15,000.
Medical Board of Australia v Owen[33]
I certify that the preceding paragraph(s) comprise the reasons for decision of the Supreme Court of Western Australia.
[1] Medical Board of Australia and Nadkarni [2021] WASAT 123.
[2] Jemielita v The Medical Board of Western Australia, unreported; SCt of WA; Library No 920584; 13 November 1992, Owen J at 140 - 142.
[3] Richter v Walton [1993] NSWCA 233 at 6 - 7 (Kirby P & O'Keefe AJA).
[4] Craig v Medical Board of South Australia [2001] SASC 169; (2001) 79 SASR 545 [41] (Doyle CJ; Williams & Martin JJ agreeing).
[5] Health Care Complaints Commission v Do [2014] NSWCA 307 [35] (Meagher JA; Basten & Emmett JJA agreeing).
[6] Medical Board of Australia v Woollard [2017] WASCA 64; (2017) 51 WAR 32 [130] (Newnes & Murphy JJA), [268] (Mitchell JA).
[7] Law Society of New South Wales v McNamara (1980) 47 NSWLR 72, 76 (Reynolds JA).
[8] Guss v Law Institute of Victoria Ltd [2006] VSCA 88 [28] (Maxwell P; Callaway & Chernov JJA agreeing).
[9] Quinn v Law Institute of Victoria Ltd [2007] VSCA 122; (2007) 27 VAR 1 [34] (Maxwell P), [41] (Chernov JA), [47] (Nettle JA).
[10] Papps v Medical Board of South Australia [2006] SASC 234 [52] (Gray J; Nyland & Vanstone JJ agreeing).
[11] Stirling v Legal Services Commissioner [2013] VSCA 374 [63] ‑ [68] (Warren CJ, Neave JA & Dixon AJA).
[12] House v The King [1936] HCA 40; (1936) 55 CLR 499, 504 ‑ 505 (Dixon, Evatt & McTiernan JJ).
[13] Singh v Medical Board of Australia [2019] WASCA 51.
[14] Medical Board of Australia v Tunbridge [2020] SACAT 34.
[15] Ellul v Fauser (1981) 28 SASR 300, 302 ‑ 303 (Cox J).
[16] Allen Commercial Constructions Pty Ltd v North Sydney Municipal Council [1970] HCA 42; (1970) 123 CLR 490, 499 ‑ 500 (Walsh J).
[17] Western Australian Planning Commission v Temwood Holdings Pty Ltd [2004] HCA 63; (2004) 221 CLR 30 [56] (McHugh J), [93] (Gummow & Hayne JJ), [156] (Callinan J).
[18] Paridis v Settlement Agents Supervisory Board [2007] WASCA 97; (2007) 33 WAR 361 [16] (Buss JA; Wheeler & Pullin JJA agreeing).
[19] Young v Legal Profession Complaints Committee [2022] WASCA 52 [295] ‑ [313].
[20] Osland v Secretary, Department of Justice (No 2) [2010] HCA 24; (2010) 241 CLR 320 [20], [33] (French CJ, Gummow & Bell JJ).
[21] Health Care Complaints Commission v Zacharia, unreported, NSW Medical Tribunal, 20 December 2011.
[22] Medical Board of Australia v Grant [2012] QCAT 285.
[23] Health Care Complaints Commission v Epstein [2015] NSWCATOD 21.
[24] Health Care Complaints Commission v Epstein (No 2) [2015] NSWCATOD 36 (Penalty Decision).
[25] Medical Board of Australia and Singh [2017] WASAT 33.
[26] Medical Board of Australia and Singh [2017] WASAT 33 (S) [39], [44] and [57] (Penalty Decision).
[27] Medical Board of Australia and Singh [2017] WASAT 33 (S) (Penalty Decision).
[28] Singh v Medical Board of Australia [2018] WASCA 125.
[29] Singh v Medical Board of Australia [2019] WASCA 51.
[30] Medical Board of Australia v Hadges [2018] SAHPT 6.
[31] Medical Board of Australia v Tunbridge [2020] SACAT 34.
[32] Medical Board of Australia v Marzola [2020] SACAT 116.
[33] Medical Board of Australia v Owen [2021] SACAT 7.
(1968) 117 CLR 177
(2001) 79 SASR 545
(2017) 51 WAR 32
(1980) 47 NSWLR 72
(1936) 55 CLR 499
(2004) 221 CLR 30
(1981) 28 SASR 300
(1970) 123 CLR 490
(2007) 33 WAR 361
(2010) 241 CLR 320